Filing Details
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2009-04-07 11:47:13
- Reporting Period:
- 2009-04-03
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 727510 | Enzon Pharmaceuticals Inc | ENZN | () |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1323791 | Stephen Paul Davit | C/O Enzon Pharmaceuticals, Inc. 685 Route 202/206 Bridgewater NJ 08807 | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2009-04-03 | 2,826 | $6.12 | 68,616 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Billionaire Hedge Funds
